Guardant Health
GH
#1530
Rank
$13.52 B
Marketcap
$104.17
Share price
2.11%
Change (1 day)
186.42%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of September 2025 : -$0.36 Billion USD

According to Guardant Health 's latest financial reports the company has -$0.36 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-$0.14 Billion-188%
2023-12-31$$0.15 B163.68%
2022-12-31$$60.18 M-90.67%
2021-12-31$$0.64 B-52.42%
2020-12-31$$1.35 B59.86%
2019-12-31$$0.84 B61.54%
2018-12-31$$0.52 B70.1%
2017-12-31$$0.30 B287.23%
2016-12-31$$79.69 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Natera
NTRA
$1.25 B-453.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
$2.11 B-697.69%๐Ÿ‡บ๐Ÿ‡ธ USA